Neisseria Gonorrhoeae vaccine and rDNA hepatitis core antigen vaccine
Govt. announces availability of the U.S. owned inventions for licensing, according to Natl. Technical Information Service announcement in Sept. 11 Federal Register notice. For more information contact: Office of Federal Patent Licensing, U.S. Dept. of Commerce, P.O. Box 1423, Springfield, VA 22151
You may also be interested in...
Taiwan’s JHL Biotech has rebranded itself as Eden Biologics at the same time as it has announced progress on clinical trials for its denosumab biosimilar candidate.
Starpharma's COVID-busting Viraleze antiviral nasal spray will soon be available across Europe, included the UK. But will it fall foul of local evidence requirements, for example in France, where the country's medicines agency has halted the sale of Pharma & Beauty (P&B) Group's COV-Defense spray until its efficacy against COVID has been confirmed by human-based studies?
Coronavirus Update: Moderna’s Variant-Targeting Vaccine Moves Into Trial, J&J Looks Set For US Authorization
A round up of COVID-19 developments, also including news on the EMA beginning a rolling review of Celltrion's antibody therapy, and progress for Novavax and Moderna in Japan.